Literature DB >> 871465

Dilemma of the swollen optic disc: a fluorescein retinal angiography study.

N E Cartlidge, R C Ng, P J Tilley.   

Abstract

In all of 100 consecutive patients referred for retinal angiography with a clinical diagnosis of probable or possible papilloedema a definite diagnosis was made from neurological assessment, neuroradiological investigations, and follow-up. The cases have been divided into 2 groups--those with proved papilloedema and those which have been called either normal or pseudopapilloedema. In all cases the retinal angiograms showed normal or increased optic disc vascularity and normal or increased early and late disc fluorescence. On the basis of these alone clear differences could be shown between the groups. All cases with papilloedema showed a combination of either excess late fluorescence with excess early fluorescence or excess late fluorescence with excess disc vascularity. Only 2 cases of pseudopapilloedema (both with optic disc drusen) showed this combination, and in both the pattern of disc fluorescence was different from that seen in papilloedema. Retinal angiography therefore seems to be of considerable value in differentiating true from pseudopapilloedema, though this is possible only when each stage of the angiogram is carefully studied.

Entities:  

Mesh:

Year:  1977        PMID: 871465      PMCID: PMC1042987          DOI: 10.1136/bjo.61.6.385

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  FLUORESCENCE PHOTOGRAPHY OF RETINAL VESSELS AND OPTIC DISCS IN PAPILLEDEMA.

Authors:  N J DAVID; A HEYMAN; L M HART
Journal:  Trans Am Neurol Assoc       Date:  1963

2.  Pseudopapilledema: anomalous elevation of optic disk. Pitafalls in diagnosis and management.

Authors:  W F HOYT; M E PONT
Journal:  JAMA       Date:  1962-07-21       Impact factor: 56.272

3.  Optic disc vasculitis.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1972-09       Impact factor: 4.638

4.  Fluorescein. 1. Technical aspects.

Authors:  E Rosen
Journal:  Manch Med Gaz       Date:  1967-10

5.  Differentiation of papilloedema from pseudo-papilloedema by fluorescein ophthalmoscopy.

Authors:  H G Bynke; L Aberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

6.  Fine structure observations on experimental papilledema in the rhesus monkey.

Authors:  H S Schutta; T R Hedges
Journal:  J Neurol Sci       Date:  1971-01       Impact factor: 3.181

7.  Fluorescein fundus photography in the detection of early papilloedema and its differentiation from pseudo-papilloedema.

Authors:  S J Miller; M D Sanders; T Ffytche
Journal:  Lancet       Date:  1965-10-02       Impact factor: 79.321

  7 in total
  7 in total

Review 1.  Drusen of the optic disc.

Authors:  Byron L Lam; Christopher G Morais; Joshua Pasol
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

Review 2.  Fluorescein angiographic identification of optic disc drusen with and without optic disc edema.

Authors:  Stacy L Pineles; Anthony C Arnold
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

3.  Interpreting fluorescein angiograms.

Authors:  B Harney
Journal:  BMJ       Date:  1993-01-02

4.  Parsons' papilloedema, 70 years on.

Authors: 
Journal:  Br Med J       Date:  1978-02-04

Review 5.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

Review 6.  Perspectives on diagnosis and management of adult idiopathic intracranial hypertension.

Authors:  Irini Chatziralli; Panagiotis Theodossiadis; George Theodossiadis; Ioannis Asproudis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-04       Impact factor: 3.117

7.  Optical Coherence Tomography Angiography in Papilledema Compared With Pseudopapilledema.

Authors:  Masoud Aghsaei Fard; Alireza Sahraiyan; Jalil Jalili; Marjane Hejazi; Yanin Suwan; Robert Ritch; Prem S Subramanian
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-01-02       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.